Literature DB >> 31151658

Addressing the impact of opioids on women and children.

Diana W Bianchi1, Matthew W Gillman2.   

Abstract

Women and children bear a substantial part of the burden of opioid overuse in the United States. Opioid use during pregnancy can lead to neonatal opioid withdrawal syndrome, and both the mothers and babies may be at higher risk of opioid use and its consequences later in the life course, setting up intergenerational cycles of opioid overuse. As part of the HEAL (Helping to End Addiction Long-term) Initiative of the National Institutes of Health, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the Environmental influences on Child Health Outcomes program are together launching observational and intervention research programs to interrupt these cycles, beginning with opportunities in pregnancy and the newborn period. The Eunice Kennedy Shriver National Institute of Child Health and Human Development has also launched programs to find alternatives to opioids for painful conditions in women of reproductive age, including a range of gynecologic conditions. These coordinated efforts promise to help turn the tide against the opioid crisis by providing the necessary evidence to improve care for women and children affected by these substances. Published by Elsevier Inc.

Entities:  

Keywords:  children; opioids; women

Year:  2019        PMID: 31151658     DOI: 10.1016/j.ajog.2019.02.050

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  4 in total

1.  An Examination of Child and Adolescent Neurodevelopment Through National Institutes of Health Studies.

Authors:  Nora D Volkow; Joshua A Gordon; George F Koob; Linda S Birnbaum; Janine A Clayton; Walter J Koroshetz; Diana W Bianchi; Gary H Gibbons; William T Riley; Eliseo J Pérez-Stable; Robert T Croyle
Journal:  Public Health Rep       Date:  2020-01-22       Impact factor: 2.792

2.  Physiologically Based Pharmacokinetic Modeling of Oxycodone in Children to Support Pediatric Dosing Optimization.

Authors:  Liang Zheng; Miao Xu; Shi-Wei Tang; Hao-Xin Song; Xue-Hua Jiang; Ling Wang
Journal:  Pharm Res       Date:  2019-10-25       Impact factor: 4.200

3.  Opioids affect the fetal brain: reframing the detoxification debate.

Authors:  Steve N Caritis; Ashok Panigrahy
Journal:  Am J Obstet Gynecol       Date:  2019-07-16       Impact factor: 8.661

4.  Characterization of the intergenerational impact of in utero and postnatal oxycodone exposure.

Authors:  Katherine E Odegaard; Victoria L Schaal; Alexander R Clark; Sneh Koul; Austin Gowen; Jagadesan Sankarasubramani; Peng Xiao; Chittibabu Guda; Steven J Lisco; Sowmya V Yelamanchili; Gurudutt Pendyala
Journal:  Transl Psychiatry       Date:  2020-09-23       Impact factor: 6.222

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.